Stock Track | WUXI BIO Soars 5.01% in Intraday Trading on $400 Million Share Buyback Announcement

Stock Track
05/26

WUXI BIO's stock surged 5.01% during intraday trading on Tuesday, following the company's announcement of a significant share repurchase program.

The biopharmaceutical company revealed plans to buy back up to US$400 million worth of its shares in the open market. Management stated that the current market price does not reflect the company's intrinsic value or actual business prospects, viewing the substantial buyback authorization as a strong signal of confidence in its future development outlook.

The board resolution, approved on May 24, 2026, authorizes the repurchase of up to 407 million shares, representing approximately 10% of the total issued shares. The company emphasized that all buybacks will be executed in compliance with applicable regulations and market conditions.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10